Replies to post #197979 on Innovation Pharmaceuticals Inc (IPIX)

[untohim]

we already know if b-om is as good as preliminary results leo will seek fast track. Not worried about a ph2b with b-up, because it will then be sought after by BP...as for K, we better pray that activating p53 doesn't catch fire with tumor shrinkage efficacy because the sciencesmiths of the world may have to give it a second look...lets not to forget about praying for P which aleady is in protective mode with the alpha and investigator bias groups, whose only results that we'll see is in January 18 imo, all imo

[Pepperchino]

I think 2nd half of 2018 can be achieved if Leo and team stay laser focused like they have been this year. They've made AMAZING progress this year IMO.

[groton68]

Stop already. Outright false. Leo had limited funds to proceed with UP and OM. ABSSSI was $30 million alone.

[sox040713]

If B-OM top-line result is similar to interim analysis, Phase 2b won't be needed. It'll go straight to Phase 3 with possible BTD. I expect B-OM to be approved first.

UP needs a 2b definitely and OM might.

[Jhawker]

Are you joking? Antibiotics are worth but a fraction of what the anti-inflammatory properties are worth. Why would we spend well over $30m on 1 trial when B-OM and B-UP will be worth more and create revenue for us quicker.